T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Fortinet
FTNT
|
+$2.09B |
| 2 |
Rockwell Automation
ROK
|
+$1.46B |
| 3 |
Autodesk
ADSK
|
+$1.19B |
| 4 |
Citigroup
C
|
+$1.11B |
| 5 |
ConocoPhillips
COP
|
+$1.08B |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$3.23B |
| 2 |
GE Aerospace
GE
|
+$2.12B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.46B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.17B |
| 5 |
Philip Morris
PM
|
+$1.06B |
Sector Composition
| 1 | Technology | 32.25% |
| 2 | Healthcare | 15.42% |
| 3 | Financials | 10.99% |
| 4 | Consumer Discretionary | 10.37% |
| 5 | Communication Services | 8.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Pharvaris
PHVS
$1.49B
| $17.5M | ﹤0.01% |
757,915
-84,783
| -10% | -$1.96M |
|
1002
Graco
GGG
$14B
| $17.5M | ﹤0.01% |
187,354
-8,226
| -4% | -$769K |
|
1003
Tenaya Therapeutics
TNYA
$196M
| $17.5M | ﹤0.01% |
3,346,522
-1,198,021
| -26% | -$6.27M |
|
1004
Teradata
TDC
$2B
| $17.4M | ﹤0.01% |
449,954
-169,890
| -27% | -$6.57M |
|
1005
Carlisle Companies
CSL
$15.6B
| $17.4M | ﹤0.01% |
44,381
+1,429
| +3% | +$560K |
|
1006
Jack Henry & Associates
JKHY
$11.7B
| $17.3M | ﹤0.01% |
99,707
+1,397
| +1% | +$243K |
|
1007
C4 Therapeutics
CCCC
$189M
| $17.3M | ﹤0.01% |
2,115,477
-443,003
| -17% | -$3.62M |
|
1008
Coty
COTY
$3.57B
| $17.3M | ﹤0.01% |
1,443,577
-695,982
| -33% | -$8.32M |
|
1009
Gibraltar Industries
ROCK
$1.78B
| $17.2M | ﹤0.01% |
214,150
-1,628
| -0.8% | -$131K |
|
1010
Fortune Brands Innovations
FBIN
$7.12B
| $17.2M | ﹤0.01% |
203,630
-3,666
| -2% | -$310K |
|
1011
Alliant Energy
LNT
$16.7B
| $17.1M | ﹤0.01% |
339,408
+7,100
| +2% | +$358K |
|
1012
A10 Networks
ATEN
$1.26B
| $17M | ﹤0.01% |
1,242,792
+34,115
| +3% | +$467K |
|
1013
iShares MSCI EAFE ETF
EFA
$67.1B
| $16.9M | ﹤0.01% |
211,128
+9,204
| +5% | +$735K |
|
1014
Universal Health Services
UHS
$12.2B
| $16.8M | ﹤0.01% |
92,215
-1,234
| -1% | -$225K |
|
1015
Cadre Holdings
CDRE
$1.32B
| $16.7M | ﹤0.01% |
460,500
+113,722
| +33% | +$4.12M |
|
1016
Symbotic
SYM
$5.32B
| $16.6M | ﹤0.01% |
369,646
+620
| +0.2% | +$27.9K |
|
|
JNPR
1017
DELISTED
Juniper Networks
JNPR
| $16.4M | ﹤0.01% |
443,713
-1,144
| -0.3% | -$42.4K |
|
1018
Amicus Therapeutics
FOLD
$2.46B
| $16.4M | ﹤0.01% |
1,389,361
+12,003
| +0.9% | +$141K |
|
1019
Apollo Global Management Series A
APO.PRA
$2.09B
| – | – |
0
| – | – |
|
1020
AES
AES
$9.17B
| $16.3M | ﹤0.01% |
907,170
-5,764
| -0.6% | -$103K |
|
1021
BrightSpring Health Services
BTSG
$4.69B
| $16.3M | ﹤0.01% |
+1,495,724
| New | +$16.3M |
|
1022
Eastman Chemical
EMN
$7.71B
| $16M | ﹤0.01% |
159,474
+750
| +0.5% | +$75.2K |
|
1023
Autoliv
ALV
$9.68B
| $15.9M | ﹤0.01% |
132,341
+4,844
| +4% | +$583K |
|
1024
Atour Lifestyle Holdings
ATAT
$5.48B
| $15.9M | ﹤0.01% |
883,921
+693,322
| +364% | +$12.4M |
|
1025
Crown Holdings
CCK
$11.2B
| $15.8M | ﹤0.01% |
198,984
+36,895
| +23% | +$2.92M |
|